Michael Goodwin
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 10
-
- Cancer therapeutics and mechanisms 4
- Phenothiazines and Benzothiazines Synthesis and Activities 4
- Biochemical and Molecular Research 3
- Co-authors
- Clifton E. Barry (14 shared papers)Helena I. Boshoff (11 shared papers)Michael Zimmermann (1 shared paper)Uwe Sauer (1 shared paper)Shinya Watanabe (1 shared paper)Ujjini H. Manjunatha (5 shared papers)Cynthia S. Dowd (5 shared papers)Thomas H. Keller (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)PLoS Pathogens (1 paper)PLoS Biology (1 paper)Cell chemical biology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Africa
In The Last Decade
Michael Goodwin
14 papers receiving 568 citations
Peers
Comparison fields: 5 of 68
- Infectious Diseases 366
- Molecular Medicine 56
- Epidemiology 210
- Organic Chemistry 153
- Molecular Biology 290
Countries citing papers authored by Michael Goodwin
This map shows the geographic impact of Michael Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Goodwin more than expected).
Fields of papers citing papers by Michael Goodwin
This network shows the impact of papers produced by Michael Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Goodwin. The network helps show where Michael Goodwin may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Goodwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 181 | |
| 2 | 2012 | 90 | |
| 3 | 2005 | 69 | |
| 4 | 2009 | 67 | |
| 5 | 2008 | 60 | |
| 6 | 2011 | 36 | |
| 7 | 2018 | 29 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 9 | |
| 10 | 2019 | 9 | |
| 11 | 2004 | 8 | |
| 12 | 2006 | 6 | |
| 13 | 2024 | 1 | |
| 14 | 2009 | 1 |
About Michael Goodwin
Michael Goodwin is a scholar working on Infectious Diseases, Molecular Biology, Organic Chemistry, Epidemiology and Surgery, having authored 14 papers that have together received 579 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Mycobacterium research and diagnosis (4 papers), Cancer therapeutics and mechanisms (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers), Biochemical and Molecular Research (3 papers), Microbial Natural Products and Biosynthesis (2 papers), Synthesis and biological activity (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). The work is most often cited by research in Infectious Diseases (366 citations), Molecular Medicine (56 citations), Epidemiology (210 citations), Organic Chemistry (153 citations) and Molecular Biology (290 citations). Michael Goodwin has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Clifton E. Barry, Helena I. Boshoff, Michael Zimmermann, Uwe Sauer, Shinya Watanabe, Ujjini H. Manjunatha, Cynthia S. Dowd, Thomas H. Keller, Laura E. Via and Véronique Dartois. Their work appears in journals such as Journal of Medicinal Chemistry, PLoS Pathogens, PLoS Biology, Cell chemical biology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.